- Bayer’s strongest-ever pharma portfolio and promising pipeline drive future growth Bangkok Post
- Newly Published Phase 3 OCEANIC-STROKE Trial Data Show Asundexian Reduces Recurrent Ischemic Stroke Risk NeurologyLive
- Bayer pushes beyond limits of treatment in stroke, heart failure, and prostate cancer koreabiomed.com
- New anti-clotting medication lowers risk of stroke without added bleeding Medical Xpress
- Bayers Asundexian Cuts Stroke Risk by 26% in Phase III Study Voice of Healthcare
Related Posts
Man worked on farm for five hours with heart attack
Darren Kidd/BHF Since his heart attack, Robert Nevin has adjusted his daily farming routine A 60-year-old man who spent a day working on his farm […]
Topsy-turvy temp leads to flu cocktail | Kolkata News
Kolkata: Close on the heels of Nipah and multiple other viruses, an unidentified virus with severe symptoms, similar to an intense form of influenza, struck […]
Poliovirus detected in 40 sewage samples across Pakistan in December 2025-Xinhua
ISLAMABAD, Jan. 18 (Xinhua) — Poliovirus has been detected in sewage samples from 40 districts across Pakistan, according to test results from the Regional Reference […]